"Enhancing Liposarcoma Prognosis - A New Predictive Scoring System Integrating Histopathological Insights"

Area of Science:

• Oncology
• Pathology
• Soft Tissue Sarcoma Research

Background:

• Liposarcomas are malignant soft tissue tumors with varied prognoses.
• Distinct subtypes exhibit unique genetic alterations influencing clinical behavior and treatment response.

Purpose of the Study:

• To analyze clinical and histopathological features impacting liposarcoma prognosis.
• To introduce a novel scoring system for predicting disease progression and survival risk in liposarcoma patients.

Main Methods:

• Retrospective multicentric study of 77 liposarcomas (2009-2023).
• Evaluation of patient demographics, tumor characteristics (location, dimensions, subtype, mitotic index, necrosis), and follow-up data for metastasis and survival.

Main Results:

• Progression-free survival correlated with lower mitotic index, somatic soft-tissue location, well-differentiated/myxoid subtypes, and absence of necrosis.
• Overall survival was negatively impacted by older age, higher mitotic index, dedifferentiated/pleomorphic subtypes, and tumor necrosis.
• Tumor location, mitotic index, and necrosis are strong predictors of liposarcoma evolution.

Conclusions:

• A new scoring system integrating histologic subtype, mitotic index, and tumor necrosis can predict liposarcoma progression and survival.
• This two-tiered system classifies liposarcomas into low- and high-risk categories for personalized therapy.
• Improved risk stratification may help prevent relapses, reduce metastasis, and enhance patient outcomes.